Fund Holdings — Carlyle Group Inc.

Total Portfolio Value:
$1.59B
Total Bought:
$124.92M
Total Sold:
$273.06M
Net Transaction:
-$148.14M
Notable People:
Harvey Mitchell Schwartz
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
QuidelOrtho Corporation(QDEL)12,460,18312,460,1830$918.32M$597.34M37.66%-$320.97M
ZoomInfo Technologies Inc.(GTM)35,244,47426,244,474-9,000,000$651.67M$420.70M26.52%-$230.97M
Soleno Therapeutics Inc2,857,8044,071,562+1,213,758$115.04M$173.12M10.91%+$58.08M
Vitru Ltd6,246,4716,246,4710$98.44M$94.01M5.93%-$4.43M
Verona Pharma PlcADS2,457,5002,457,5000$48.81M$39.44M2.49%-$9.36M
Getty Images Holdings IncCL A(GETY)9,394,3199,212,799-181,520$49.32M$38.23M2.41%-$11.09M
Phathom Pharmaceuticals, Inc.(PHAT)3,496,8083,496,8080$31.93M$37.10M2.34%+$5.18M
Jasper Therapeutics, Inc.(JSPR)01,066,189+1,066,189$0$31.30M1.97%+$31.30M
Hillevax Inc1,838,4861,838,4860$29.51M$30.50M1.92%+$992.8K
GDS Holdings LimitedADS(GDS)4,072,6244,072,6240$37.14M$27.08M1.71%-$10.06M
SEACOR Marine Holdings Inc.(SMHI)1,314,1641,314,1640$16.55M$18.32M1.15%+$1.77M
Q32 Bio Inc.(QTTB)01,102,741+1,102,741$0$18.07M1.14%+$18.07M
Invitation Homes Inc.(INVH)477,500477,5000$16.29M$17.00M1.07%+$716.3K
CubeSmart(CUBE)220,500220,5000$10.22M$9.97M0.63%-$249.2K
Adicet Bio Inc2,115,3852,948,718+833,333$3.98M$6.90M0.43%+$2.92M
Krispy Kreme, Inc.(DNUT)0340,748+340,748$0$5.19M0.33%+$5.19M
Reneo Pharmaceuticals Inc2,698,9572,698,9570$4.32M$4.45M0.28%+$134.9K
Smart Sh Global LtdADS4,810,2094,810,2090$2.41M$3.16M0.20%+$752.3K
Effector Therapeutics Inc0192,884+192,884$0$2.72M0.17%+$2.72M
SunPower Inc.(SPWR)2,745,8794,936,483+2,190,604$4.26M$2.72M0.17%-$1.54M
Spruce Biosciences Inc2,896,5182,896,5180$8.37M$2.28M0.14%-$6.09M
N-able, Inc.(NABL)093,732+93,732$0$1.23M0.08%+$1.23M
Solarwinds Corp093,735+93,735$0$1.18M0.07%+$1.18M
Broadcom Inc.(AVGO)0755+755$0$1.00M0.06%+$1.00M
Nu Holdings Ltd.CL A(NU)072,341+72,341$0$863.0K0.05%+$863.0K
Nucana PlcADR3,333,3333,333,3330$967.0K$845.3K0.05%-$121.7K
DoorDash, Inc.CL A(DASH)04,156+4,156$0$572.4K0.04%+$572.4K
Spyre Therapeutics, Inc.(SYRE)9,6209,6200$203.9K$364.8K0.02%+$160.8K
Meta Data LimitedADS314,400314,4000$306.0K$240.6K0.02%-$65.4K
Confluent IncCL A07,683+7,683$0$234.5K0.01%+$234.5K
Exicure Inc281,636281,6360$163.4K$160.5K0.01%-$2.9K
Molecular Templates Inc13,33313,3330$49.3K$28.7K0.00%-$20.7K
Effector Therapeutics Inc4,822,1140-4,822,114$2.23M$0—-$2.23M
Jasper Therapeutics, Inc.(JSPR)8,761,8910-8,761,891$6.67M$0—-$6.67M
Vera Therapeutics, Inc.CL A(VERA)1,438,1550-1,438,155$22.10M$0—-$22.10M
Page 1 of 1
Carlyle Group Inc. — 13F Holdings — Q1 2024 | TickerTrail